How it all Plays Out - Research on Lawson Products, PAM Transportation Services, Hallmark Financial Services and Proteon Therapeutics

NEW YORK, NY / ACCESSWIRE / December 7, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Lawson Products Inc. (NASDAQ: LAWS), PAM Transportation Services Inc. (NASDAQ: PTSI), Hallmark Financial Services Inc. (NASDAQ: HALL) and Proteon Therapeutics Inc. (NASDAQ: PRTO). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

LAWS Research Package: http://www.traders-choice.com/pdf?s=LAWS

PTSI Research Package: http://www.traders-choice.com/pdf?s=PTSI

HALL Research Package: http://www.traders-choice.com/pdf?s=HALL

PRTO Research Package: http://www.traders-choice.com/pdf?s=PRTO

============

Highlights from today's reports include:

On Friday, December 4, 2015, the NASDAQ Composite ended at 5,142.27, up 2.08%, the Dow Jones Industrial Average advanced 2.12% to finish the day at 17,847.63 and the S&P 500 closed at 2,091.69, up 2.05%.

- Lawson Products Inc.'s stock edged lower by 0.80% to close Friday's session at USD 27.30. The stock traded above its 50-day and 200-day moving average of USD 26.51 and USD 24.54, respectively. The company's shares oscillated between USD 27.01 and USD 27.78. The stock recorded a trading volume of 0.04 million shares, which was above its 52-week average volume of 0.03 million shares. Over the last three days, Lawson Products Inc.'s shares have declined by 1.94% and in the past one week the stock has moved down 2.99%. However, over the last three months, the stock has gained 21.60% and in the past six months, the shares have picked up 23.53%. Further, the company is trading at a price to earnings (TTM) ratio of 272.21 and at a price to book (MRQ) ratio of 3.67. Additionally, the stock is trading at a price to cash flow (TTM) ratio of 19.37 and at a price to sales (TTM) ratio of 0.86.

- The stock of PAM Transportation Services Inc. gained 2.02% to close Friday's session at USD 30.25. The shares of the company moved in the range of USD 28.93 and USD 30.70, marking a new 52-week low during the session. A trading volume of 0.03 million shares was recorded, which was greater than its 150-day daily average volume of 0.02 million shares. Over the last five days PAM Transportation Services Inc.'s shares have declined by 10.29% and in the past one month the shares have lost 24.34%. Additionally, over the last three months the stock has declined 20.87% and in the past six months the shares have registered a loss of 51.03%. The stock traded below its 50-day and 200-day moving averages of USD 36.32 and USD 49.64, respectively. Further, the company is trading at a price to earnings (TTM) ratio of 11.08 and a price to book (MRQ) ratio of 2.15.

- Hallmark Financial Services Inc.'s stock decreased by 0.16% to close Friday's session at USD 12.59, above its 50-day and 200-day moving average of USD 12.39 and USD 11.54, respectively. The company's shares fluctuated in the range of USD 12.52 and USD 12.76. A total of 0.03 million shares exchanged hands, which was lesser than its 50-day daily average volume of 0.04 million shares. Over the last three days, Hallmark Financial Services Inc.'s shares have declined by 0.87% while in the past one week the stock has moved up 1.04%. Over the last three months, the stock has gained 9.67% and in the past six months, the shares have picked up 10.54%. Further, the company is trading at a price to earnings (TTM) ratio of 10.95, which compares to a historical PE ratio of 17.44. Additionally, the stock is trading at a price to cash flow (TTM) ratio of 4.38.

- Proteon Therapeutics Inc.'s stock added 0.62% to close Friday's session at USD 14.71. The stock traded above its 50-day moving average of USD 14.64, while trading slightly below its 200-day moving average of USD 14.81. The company's shares oscillated between USD 14.58 and USD 15.50. The stock recorded a trading volume of 0.02 million shares, which was below its 52-week average volume of 0.03 million shares. Over the last five days, Proteon Therapeutics Inc.'s shares have declined by 3.86% while in the past one month, the stock has gained a momentum of 2.01%. In addition, over the last three months the stock has gained 6.13% and year to date the shares have picked up 41.44%. On a compounded total return basis, shares of Proteon Therapeutics Inc. have returned 67.73% in the last one year. Further, the company is trading at a price to book (MRQ) ratio of 3.5.

--

About Trader's Choice:

Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

E-mail: press (at) traders-choice.com

SOURCE: Trader's Choice


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.